METheraHld (METX) Stock Overview

ME Therapeutics Holdings Inc., a preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology. The company was incorporated in 2021 and is headquartered in Vancouver, Canada.

METX Stock Information

Symbol

METX

Address

177 Robson StreetVancouver, BC V6B 0N3Canada

Founded

Trading hours

Website

https://www.metherapeutics.com

Country

🇨🇦 Canada

Phone Number

METheraHld (METX) Price Chart

METheraHld Overview: Key Details and Summary

Stock data	2023	Change
Price	$2.08	N/A
Market Cap	$49.03M	N/A
Shares Outstanding	23.56M	-0.19%
Employees	0	N/A
Shareholder Equity	523.39K	44.37%

Valuation	2023	Change
P/E Ratio	-7.52	N/A
P/B Ratio	93.67	N/A

Growth	2023	Change
Return on Equity	-8.6412	N/A

Earnings	2023	Change
Revenue	$0	N/A
Earnings	-$4.52M	N/A
EPS	-0.2767	N/A
Earnings Yield	-0.133	N/A

Financial Strength	2023	Change
Total Assets	$466.02K	N/A
Cash on Hand	$448.88K	N/A
Debt to Equity	0.1968	190.77%
Current Ratio	$4.52	-59.79%